New drug trial aims to restore periods and protect bones
NCT ID NCT07235917
Summary
This study is testing an experimental drug called mibavademab in adult women whose periods have stopped due to a brain signaling problem (functional hypothalamic amenorrhea). The main goals are to see if the drug can safely help the body restart the natural hormone cycle needed for ovulation and menstruation, and to check if it also improves bone health. About 34 participants will receive either the drug or a placebo to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL HYPOTHALAMIC AMENORRHEA (FHA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arensia Exploratory Medicine Clinic
RECRUITINGPhoenix, Arizona, 85015, United States
-
Focus Clinical Research
RECRUITINGWest Hills, California, 91307, United States
-
OBGYN Associates of Erie
RECRUITINGErie, Pennsylvania, 16507, United States
-
Tidewater Clinical Research - Tidewater Physicians for Women
RECRUITINGNorfolk, Virginia, 23502, United States
-
Zillan Clinical Research
RECRUITINGHouston, Texas, 77082, United States
Conditions
Explore the condition pages connected to this study.